Phio Pharmaceuticals Corp. (Nasdaq:PHIO)
Health Care/Life Sciences • Biotechnology
CIK 1533040
Company
Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.
Address
11 Apex Drive
Suite 300A PMB 2006
Marlborough, Massachusetts 01752
11 Apex Drive
Suite 300A PMB 2006
Marlborough, Massachusetts 01752
Employees
9
9
Stock Info
Close
$1.3900
$1.3900
Day Range
1.3000 - 1.4400
1.3000 - 1.4400
52 Week Range
1.2201 - 9.9900
1.2201 - 9.9900
Average volume
6.08M
6.08M
Short Interest
45.46K (02/14/25)
45.46K (02/14/25)
% of Float Shorted
1.07%
1.07%
Market Cap
$6.64M
$6.64M
Revenue
N/A
N/A
Net Income
-$10.83M
-$10.83M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Chairman, President & Chief Executive Officer Robert J. Bitterman Sr. |
Independent Director Jonathan E. Freeman |
Independent Director Curtis A. Lockshin |
Independent Director David H. Deming |
Independent Director Patricia A. Bradford |
Lead Independent Director Robert L. Ferrara |
SEC filings
Date | Form | Event |
---|---|---|
20 Dec, 2024 | 8-K | |
20 Dec, 2024 | 424B5 | |
19 Dec, 2024 | 8-K | |
14 Nov, 2024 | 10-Q | |
14 Nov, 2024 | 8-K | |
13 Nov, 2024 | SC 13G/A | |
7 Nov, 2024 | 8-K | |
13 Sep, 2024 | 4 | |
13 Sep, 2024 | 4 | |
13 Sep, 2024 | 4 | |
12 Sep, 2024 | 4 | |
12 Sep, 2024 | 4 | |
12 Sep, 2024 | 4 | |
15 Aug, 2024 | 4 | |
14 Aug, 2024 | 10-Q | |
14 Aug, 2024 | 8-K | |
9 Aug, 2024 | 3 | |
5 Aug, 2024 | 424B3 | |
1 Aug, 2024 | 8-K | |
1 Aug, 2024 | EFFECT | |
30 Jul, 2024 | CORRESP | |
29 Jul, 2024 | UPLOAD | |
26 Jul, 2024 | S-1 | |
24 Jul, 2024 | D | |
24 Jul, 2024 | 8-K | |
12 Jul, 2024 | 8-K | |
5 Jul, 2024 | 8-K | |
2 Jul, 2024 | 8-K | |
1 Jul, 2024 | EFFECT | |
27 Jun, 2024 | CORRESP | |
21 Jun, 2024 | 8-K | |
11 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
28 May, 2024 | 8-K | |
24 May, 2024 | UPLOAD | |
20 May, 2024 | RW | |
20 May, 2024 | S-3 | |
17 May, 2024 | S-1 | |
17 May, 2024 | 8-K | |
17 May, 2024 | 424B5 | |
9 May, 2024 | 10-Q | |
9 May, 2024 | 8-K | |
8 May, 2024 | DEF 14A | |
8 May, 2024 | ARS | |
8 May, 2024 | DEFA14A | |
22 Apr, 2024 | PRE 14A | |
2 Apr, 2024 | 8-K | |
1 Apr, 2024 | 10-K | |
5 Mar, 2024 | 4 | |
27 Feb, 2024 | 4 | |
22 Feb, 2024 | 4 | |
20 Feb, 2024 | 4 | |
6 Feb, 2024 | SC 13G/A | |
26 Jan, 2024 | 8-K | |
28 Dec, 2023 | 424B3 | |
27 Dec, 2023 | EFFECT | |
22 Dec, 2023 | CORRESP | |
21 Dec, 2023 | UPLOAD | |
19 Dec, 2023 | D | |
19 Dec, 2023 | S-1 | |
8 Dec, 2023 | 8-K | |
9 Nov, 2023 | 10-Q | |
9 Nov, 2023 | 8-K | |
3 Oct, 2023 | 4 | |
29 Sep, 2023 | S-8 | |
21 Aug, 2023 | 8-K | |
10 Aug, 2023 | 8-K | |
10 Aug, 2023 | 10-Q | |
26 Jul, 2023 | 8-K | |
5 Jul, 2023 | 4 | |
15 Jun, 2023 | 4 | |
14 Jun, 2023 | UPLOAD | |
14 Jun, 2023 | CORRESP | |
13 Jun, 2023 | D | |
9 Jun, 2023 | ARS | |
9 Jun, 2023 | DEFA14A | |
9 Jun, 2023 | DEF 14A | |
8 Jun, 2023 | S-1 | |
2 Jun, 2023 | 8-K | |
1 Jun, 2023 | 424B5 | |
24 May, 2023 | 8-K | |
16 May, 2023 | 8-K | |
11 May, 2023 | 8-K | |
11 May, 2023 | 10-Q | |
10 May, 2023 | 424B3 | |
9 May, 2023 | EFFECT | |
5 May, 2023 | UPLOAD | |
5 May, 2023 | CORRESP | |
2 May, 2023 | D | |
28 Apr, 2023 | S-1 | |
20 Apr, 2023 | 424B3 | |
20 Apr, 2023 | 424B3 | |
20 Apr, 2023 | 424B3 | |
20 Apr, 2023 | 424B3 | |
20 Apr, 2023 | 424B3 | |
20 Apr, 2023 | 424B3 | |
20 Apr, 2023 | 8-K | |
20 Apr, 2023 | 8-K | |
19 Apr, 2023 | 424B5 | |
18 Apr, 2023 | 8-K | |
17 Apr, 2023 | 8-K | |
22 Mar, 2023 | 8-K | |
22 Mar, 2023 | 10-K | |
10 Mar, 2023 | 8-K | |
3 Mar, 2023 | 4 | |
22 Feb, 2023 | 4 | |
22 Feb, 2023 | 8-K | CEO Change |
22 Feb, 2023 | 4 | |
22 Feb, 2023 | 4 | |
22 Feb, 2023 | 4 | |
22 Feb, 2023 | 4 | |
22 Feb, 2023 | 4 | |
22 Feb, 2023 | 4 | |
17 Feb, 2023 | 4 | |
13 Feb, 2023 | 8-K | |
8 Feb, 2023 | SC 13G/A | |
25 Jan, 2023 | 8-K | |
6 Jan, 2023 | 8-K | |
21 Dec, 2022 | 8-K | |
15 Dec, 2022 | 4 | |
8 Dec, 2022 | 4 | |
6 Dec, 2022 | 4 | |
5 Dec, 2022 | 4 | |
2 Dec, 2022 | DEFA14A | |
30 Nov, 2022 | DEF 14A | |
29 Nov, 2022 | 4 | |
28 Nov, 2022 | 4 | |
23 Nov, 2022 | D | |
16 Nov, 2022 | PRE 14A | |
16 Nov, 2022 | 4 | |
16 Nov, 2022 | 8-K | |
10 Nov, 2022 | 10-Q | |
10 Nov, 2022 | 8-K | |
3 Oct, 2022 | 4 | |
29 Sep, 2022 | 8-K | |
26 Sep, 2022 | 4 | |
26 Aug, 2022 | 8-K | |
12 Aug, 2022 | 8-K | |
11 Aug, 2022 | 10-Q | |
11 Aug, 2022 | 8-K | |
30 Jun, 2022 | DEF 14A | |
30 Jun, 2022 | DEFA14A | |
12 May, 2022 | 10-Q | |
12 May, 2022 | 8-K | |
10 May, 2022 | 8-K | CEO Change |
2 May, 2022 | 8-K | |
29 Apr, 2022 | 3 | |
29 Apr, 2022 | 10-K/A | |
22 Mar, 2022 | 8-K | |
22 Mar, 2022 | 10-K | |
3 Mar, 2022 | 4 | |
3 Mar, 2022 | 8-K | |
3 Mar, 2022 | 4 | |
16 Feb, 2022 | 4 | |
16 Feb, 2022 | 4 | |
16 Feb, 2022 | 4 | |
16 Feb, 2022 | 4 | |
16 Feb, 2022 | 4 | |
16 Feb, 2022 | 4 | |
16 Feb, 2022 | 4 | |
16 Feb, 2022 | 4 | |
11 Feb, 2022 | SC 13G/A | |
20 Jan, 2022 | SC 13G/A | |
21 Dec, 2021 | 25-NSE | |
10 Nov, 2021 | 8-K | |
10 Nov, 2021 | 10-Q | |
17 Aug, 2021 | 4 | |
12 Aug, 2021 | 10-Q | |
12 Aug, 2021 | 8-K | |
21 Jun, 2021 | 8-K | |
21 May, 2021 | EFFECT | |
19 May, 2021 | CORRESP | |
19 May, 2021 | UPLOAD | |
13 May, 2021 | S-3 | |
13 May, 2021 | 8-K | |
13 May, 2021 | 10-Q | |
6 May, 2021 | DEFA14A | |
30 Apr, 2021 | DEF 14A | |
25 Mar, 2021 | 8-K | |
25 Mar, 2021 | 10-K | |
5 Mar, 2021 | 4 | |
3 Mar, 2021 | 4 | |
3 Mar, 2021 | 4 | |
3 Mar, 2021 | 4 | |
3 Mar, 2021 | 4 | |
3 Mar, 2021 | 4 | |
3 Mar, 2021 | 4 | |
3 Mar, 2021 | 4 | |
3 Mar, 2021 | 4 | |
19 Feb, 2021 | SC 13G | |
17 Feb, 2021 | 8-K | |
17 Feb, 2021 | 424B5 | |
16 Feb, 2021 | SC 13G/A | |
16 Feb, 2021 | D | |
9 Feb, 2021 | 424B2 | |
8 Feb, 2021 | EFFECT | |
5 Feb, 2021 | CORRESP | |
4 Feb, 2021 | S-3/A | |
2 Feb, 2021 | UPLOAD | |
29 Jan, 2021 | S-3 | |
29 Jan, 2021 | SC 13G/A | |
25 Jan, 2021 | 8-K | |
5 Jan, 2021 | SC 13G/A |
Last update:2025-03-06 12:52:57.517656
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.